Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00464464 · ClinicalTrials.gov registry record · NA

Coping With Depression in Parkinson's Disease

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT00464464: Completed NA study, sponsored by Rutgers, The State University of New Jersey.

NCT00464464 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00464464, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the efficacy of a cognitive-behavioral treatment, that includes a caregiver-focused social support intervention, for depression in persons with Parkinson's disease. Individuals who are unable to travel to the study site, but are interested in participating and meet all other eligibility requirements, will be allowed to participate over the phone.

Primary Outcome

This measure uses the Hamilton Depression Rating Scale (HDRS) to express the average severity of depressive symptoms for a) all participants in the Cognitive-Behavioral Therapy condition and b) all participants in the Standard Medical Care condition, at the outset of the trial. The total score on the HDRS (range = 0 to 84) was used as the outcome measures value, with higher values indicating more severe depressive symptomatology and lower scores representing less severe depressive symptomatolog

Interventions

  • BEHAVIORAL cognitive-behavioral therapy

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2007-04
Est. Completion 2013-03
Phase NA

What the finished NCT00464464 record still lists

NCT00464464 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which cognitive-behavioral therapy is the first listed.

NCT00464464 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00464464 about?

NCT00464464 is a clinical study titled "Coping With Depression in Parkinson's Disease". The purpose of this study is to evaluate the efficacy of a cognitive-behavioral treatment, that includes a caregiver-focused social support intervention, for depression in persons with Parkinson's disease. Individuals who are unable to travel to the study site, but are interested in participating a...

What is the current status of trial NCT00464464?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2007-04. Estimated completion is 2013-03.

What interventions are being tested in trial NCT00464464?

The interventions under investigation include: cognitive-behavioral therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00464464?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00464464's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00464464, the US trial registry maintained by the National Library of Medicine. NCT00464464 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.